Yungjin Pharm Co Ltd - Asset Resilience Ratio

Latest as of September 2024: 4.23%

Yungjin Pharm Co Ltd (003520) has an Asset Resilience Ratio of 4.23% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 003520 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩10.00 Billion

≈ $6.78 Million USD Cash + Short-term Investments

Total Assets

₩236.18 Billion

≈ $160.05 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Yungjin Pharm Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Yungjin Pharm Co Ltd assets under control.

Liquid Assets Composition Over Time

This chart breaks down Yungjin Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Yungjin Pharm Co Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.00 Billion	4.23%
Total Liquid Assets	₩10.00 Billion	4.23%

Asset Resilience Insights

Limited Liquidity: Yungjin Pharm Co Ltd maintains only 4.23% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Yungjin Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yungjin Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Shenzhen Kangtai Biological Products Co Ltd SHE:300601	Drug Manufacturers - Specialty & Generic	12.99%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%
ChengDa Pharmaceuticals Co. Ltd. SHE:301201	Drug Manufacturers - Specialty & Generic	32.14%

Annual Asset Resilience Ratio for Yungjin Pharm Co Ltd (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Yungjin Pharm Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	1.32%	₩3.00 Billion ≈ $2.03 Million	₩226.60 Billion ≈ $153.56 Million	-2.60pp
2017-12-31	3.92%	₩8.00 Billion ≈ $5.42 Million	₩203.85 Billion ≈ $138.14 Million	+3.80pp
2016-12-31	0.12%	₩240.00 Million ≈ $162.64K	₩199.35 Billion ≈ $135.10 Million	-0.67pp
2014-12-31	0.79%	₩1.41 Billion ≈ $955.54K	₩178.97 Billion ≈ $121.28 Million	--

pp = percentage points

About Yungjin Pharm Co Ltd

KO:003520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$126.67 Million

₩186.92 Billion KRW

Market Cap Rank

#18372 Global

#824 in Korea

Share Price

₩1022.00

Change (1 day)

+0.29%

52-Week Range

₩1019.00 - ₩2170.00

All Time High

₩17500.00